natgillin/translations-raw huggingface dataset:
Talk to your doctor or pharmacist before using Inbrija if you have, or have ever had, or you develop: - asthma, breathing difficulties like chronic obstructive pulmonary disease (COPD) or other long term lung diseases or breathing problems; - any form of severe mental disorder like psychosis; - a heart attack, or heart beat problems. 
- astma, težave z dihanjem, kot je kronična obstruktivna pljučna bolezen (KOPB) ali druga dolgotrajna pljučna bolezen ali težave z dihanjem; - kakršna koli oblika resne duševne motnje, kot je na primer psihoza; - srčni napad ali težave z bitjem srca.
Do not use this medicine after the expiry date which is stated on the blisters and carton after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na pretisnih omotih in škatli poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
Get inhaler and strip of capsules. 
Vzemite inhalator in pretisni trak s kapsulami.
Falsenegative tests may result with the use of glucose-oxidase methods of testing for glucosuria. 
Pri uporabi metod z glukozo-oksidazo za testiranje na glukozurijo lahko pride do lažno negativnih rezultatov.
There have been rare reports of adverse reactions, including hypertension and dyskinesia, resulting from the concomitant use of tricyclic antidepressants and a levodopa/dopa-decarboxylase inhibitor. 
Obstajajo redka poročila o neželenih učinkih zaradi sočasne uporabe tricikličnih antidepresivov in levodope/zaviralca dopa-dekarboksilaze, vključno s hipertenzijo in diskinezijo.
Serious adverse reactions of allergic oedema have been reported with levodopa medicinal products but not in clinical studies with Inbrija. 
Pri zdravilih z levodopo so poročali o resnih neželenih učinkih alergijskega edema, o katerih pa v kliničnih študijah z zdravilom Inbrija niso poročali.
If this happens start again at Step 4 using a new capsule. 
Če se to vseeno zgodi, vzemite novo kapsulo in ponovno začnite s 4. korakom.
No effects were seen on male or female reproductive organs in repeat dose toxicology studies in mice, rats or monkeys with levodopa alone. 
V študijah toksičnosti pri ponavljajočih odmerkih s samo levodopo na miših, podganah in opicah niso opazili učinkov na reproduktivne organe samcev in samic.
- The used capsule should be removed from the Inbrija inhaler and the second capsule loaded into the inhaler. 
- Uporabljeno kapsulo je treba odstraniti iz inhalatorja za zdravilo Inbrija in nato vanj vstaviti naslednjo kapsulo.
It is recommended to administer this medicinal product cautiously to patients with severe renal disease (see section 4.2). 
Priporoča se previdnost pri dajanju tega zdravila bolnikom s hudo boleznijo ledvic (glejte poglavje 4.2).
Only remove 1 capsule at a time, and just before use. 
Vedno odstranite iz ovojnine samo 1 kapsulo, in to šele tik pred uporabo.
Thrombophlebitis, Hot flush 
tromboflebitis, vroči oblivi
- skin cancer; - lack of red blood cells so you are pale and feel tired; being more prone to infections because of a lack of white blood cells; lack of blood platelets which can lead to bruising and a tendency to bleed; - decreased appetite; - confusion; hallucinations; depression; anxiety; bad dreams; unable to sleep; abnormal thinking and perceptions, losing touch with reality; feeling agitated; suicidal; being disorientated; exaggerated feeling of happiness; increased sex drive; grinding of teeth; feeling paranoid and delusional; - movement disorder in which a person's muscles contract uncontrollably; sudden, sometimes unpredictable changes in symptoms, due to the return of Parkinson's disease symptoms; sleepiness; dizziness; worsening of Parkinson's disease; pins and needles; headache; tremors; seizure; sudden onset of sleep; restless legs syndrome; ataxia (disorder affecting co-ordination, balance and speech); distorted sense of taste; mental health disorders that affecting learning, memory, perception, and problem solving; Horner's syndrome (an eye disorder); dementia; 
- raka kože; - pomanjkanje rdečih krvničk, kar lahko povzroči bledico in občutek utrujenosti; povečano nagnjenost k okužbam zaradi pomanjkanja belih krvničk; pomanjkanje krvnih ploščic, ki lahko povzroči nastanek modric in nagnjenost h krvavitvam; - zmanjšan apetit; - zmedenost; halucinacije; depresijo; anksioznost (tesnobnost), neprijetne sanje; nezmožnost spanja; nenormalno razmišljanje in zaznave, izgubo stika z realnostjo; občutek nemirnosti; samomorilno razpoloženje; občutek dezorientiranosti; prekomeren občutek sreče; povečan spolni nagon; škrtanje z zobmi; paranoičnost in blodnje; - motnjo gibanja, pri kateri se mišice nenadzorovano krčijo; nenadne, včasih nepredvidljive spremembe simptomov zaradi vrnitve simptomov Parkinsonove bolezni; zaspanost; omotica;
- medicines for your Parkinson's disease called selective MAO inhibitors such as rasagiline, selegiline and safinamide, COMT inhibitors such as entacapone, tolcapone and opicapone, or anticholinergics such as orphenadrine and trihexyphenidyl; 
- zdravila za zdravljenje vaše Parkinsonove bolezni, ki jim pravimo selektivni zaviralci MAO, kot so razagilin, selegilin in safinamid, zaviralci COMT, kot so entakapon, tolkapon in opikapon, ali antiholinergiki, kot sta orfenadrin in triheksifenidil; - zdravila za duševne bolezni vključno s shizofrenijo, kot so benperidol, haloperidol, risperidon, klorpromazin, flufenazin dekanoat, fenotiazin, butirofenon ali trifluoperazin; - metoklopramid za zdravljenje siljenja na bruhanje;
Adverse reactions in clinical trials with Inbrija 
Neželeni učinki v kliničnih preskušanjih z zdravilom Inbrija
Fall a Cardiac rhythm disorder here is a combined term representing atrial fibrillation, atrial flutter, atrioventricular block, bundle branch block, sick sinus syndrome, bradycardia, and tachycardia. 
Poškodbe, zastrupitve in zapleti pri posegih padec a Tukaj uporabljeni izraz motnja srčnega ritma je kombiniran izraz, ki predstavlja atrijsko fibrilacijo, atrijsko undulacijo, atrioventrikularni blok, kračni blok, sindrom bolnega sinusa, bradikardijo in tahikardijo.
Inbrija is not recommended during pregnancy and in women of childbearing potential not using contraception. 
Zdravilo Inbrija se ne priporoča za uporabo pri nosečnicah in pri ženskah v rodni dobi, ki ne uporabljajo učinkovite kontracepcije.
Inhalation only. 
med inhalacijo.
If you have any of these symptoms, you may have a eye condition called narrow angle glaucoma, which occurs suddenly: do not take 
Če imate katerega koli od teh simptomov, imate morda bolezen oči, imenovano glavkom ozkega zakotja, ki se pojavi nenadoma: ne jemljite zdravila Inbrija in takoj poiščite nujno zdravniško pomoč.
A summary of how to use Inbrija is provided below. 
nadaljevanju je povzeto, kako se uporablja zdravilo Inbrija.
Psychotic reactions have been observed in patients receiving amantadine and levodopa. 
Pri bolnikih, ki so prejemali amantadin in levodopo, so opazili psihotične reakcije.
It is recommended to administer this medicinal product cautiously to patients with severe renal disease. 
Priporoča se previdnost pri dajanju tega zdravila bolnikom s hudo boleznijo ledvic.
Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC 
• Redno posodobljena poročila o varnosti zdravila (PSUR) Zahteve glede predložitve PSUR za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
Breast-feeding should be discontinued during treatment with Inbrija. 
Med zdravljenjem z zdravilom Inbrija je treba prenehati z dojenjem.
Talk to your doctor or pharmacist if you develop any of the symptoms below whilst using Inbrija: - sudden sleep attacks or sometimes feeling very sleepy; - changes in or worsening of your mental state, which may be severe such as psychotic and suicidal behaviour; - hallucinations, along with being confused, unable to sleep and excessive dreaming. 
- nenadni napadi spanca ali občasen občutek hude zaspanosti; - sprememba ali poslabšanje vašega duševnega stanja, ki sta lahko resna, na primer psihotično in samomorilno vedenje; - halucinacije, vključno z zmedenostjo, nezmožnostjo spanja in prekomernim sanjanjem.
Non-selective Monoamine Oxidase (MAO) inhibitors The use of non-selective MAO inhibitors with levodopa is contraindicated (see section 4.3). 
Uporaba neselektivnih zaviralcev monoaminooksidaze z levodopo je kontraindicirana (glejte poglavje 4.3).
Gastrointestinal haemorrhage has been reported with levodopa medicinal products and was observed once in Inbrija clinical studies. 
Pri zdravilih z levodopo so poročali o krvavitvi v prebavilih, ki so jo v kliničnih študijah z zdravilom Inbrija opazili enkrat.
Breathe out completely. 
Povsem izdihnite zrak iz pljuč.
Henoch-Schonlein purpura, Urticaria, 
Henoch-Schönleinova purpura, urtikarija, alopecija, sprememba barve znoja
It is recommended to administer this medicinal product cautiously to patients with severe hepatic impairment (see section 4.2). 
Priporoča se previdnost pri dajanju tega zdravila bolnikom s hudo okvaro jeter (glejte poglavje 4.2).
• Do not load 2 capsules at the same time. 
• V inhalator ne smete vstaviti 2 kapsul naenkrat.
Musculoskeletal and connective tissue disorders 
Bolezni mišično skeletnega sistema in vezivnega tkiva mišični krči,
Hypromellose Titanium dioxide (E 171) Carrageenan 
natrijev klorid Ovojnica kapsule hipromeloza titanov dioksid (E 171)
In the presence of carbidopa, the apparent terminal elimination half-life (t1/2) of levodopa following a single administration of Inbrija 66 mg (2 x 33 mg capsules) was 2.3 hours and comparable to that following an oral dose of carbidopa/levodopa 25 mg/100 mg immediate release tablets of 1.9 hours. 
V prisotnosti karbidope je bil navidezni končni razpolovni čas izločanja (t1/2) levodope po aplikaciji enkratnega odmerka 66 mg (2 × 33 mg kapsula) zdravila Inbrija 2,3 ure in je bil primerljiv s tistim po peroralnem odmerku karbidope/levodope 25 mg/100 mg tableta s takojšnjim sproščanjem (1,9 ure).
The hard capsules are supplied in Aluminium / PVC / Aluminium peel-off blisters. 
6.5 Vrsta ovojnine in vsebina Trde kapsule so pakirane v pretisne omote iz aluminija/PVC/aluminija.
92 hard capsules + 1 inhaler 
60 trdih kapsul + 1 inhalator 92 trdih kapsul + 1 inhalator
Step 4: Remove 1 capsule from package 
4. korak: Vzemite 1 kapsulo iz ovojnine.
Twist and pull off the mouthpiece. 
Zavrtite in odstranite beli ustnik.
Levodopa should be administered cautiously to patients with a history of peptic ulcer disease (because of the possibility of upper gastro-intestinal haemorrhage). 
Potrebna je previdnost pri dajanju levodope bolnikom z anamnezo peptične razjede (zaradi možnosti krvavitve v zgornjih prebavilih).
Carton containing 92 hard capsules (23 blister strips) and one inhaler. 
Škatla, ki vsebuje 92 trdih kapsul (23 pretisnih trakov) in en inhalator.
Make sure there are no capsules in the inhaler before you store it. 
Prepričajte se, da nobena kapsula ni ostala v inhalatorju.
- if you are taking certain antidepressant medicines called non-selective MAO inhibitors (e.g. 
- če jemljete določena zdravila proti depresiji, imenovana neselektivni zaviralci MAO (npr. izokarboksazid in fenelzin).
- Co-administration with non-selective monoamine oxidase (MAO) inhibitors. 
- Sočasno dajanje z neselektivnimi zaviralci monoaminooksidaze (MAO).
- The medicine must be used only with the Inbrija inhaler device. 
- To zdravilo morate zmeraj uporabljati samo z inhalatorjem za zdravilo Inbrija.
Make sure the mouthpiece is securely attached and will not fall off before moving to Step 7. 
Preden nadaljujete s 7. korakom, se prepričajte, da je ustnik varno pritrjen in da ne bo odpadel.
This is because other medicines can affect the way Inbrija works. 
To je zato, ker lahko druga zdravila vplivajo na delovanje zdravila
Breast-feeding 
blerospazem
Carton containing 60 hard capsules (15 blister strips) and one inhaler. 
Škatla, ki vsebuje 60 trdih kapsul (15 pretisnih trakov) in en inhalator.
Baseline Levodopa dose 
Izhodiščni odmerek levodope
Inbrija inhalation powder, hard capsules consist of a white powder for inhalation filled into white opaque hard capsules with “A42” printed in black on the cap of the caspule and two black bands printed on the body of the capsule. 
polnjenega v bele neprosojne trde kapsule s črnim napisom »A42« na pokrovčku kapsule in dvema črnima progama na telesu kapsule.
COMT inhibitors 
Zaviralci COMT
Step 5: Load capsule 
5. korak: Vstavite kapsulo.
If you use more Inbrija than you should (or someone accidentally swallows Inbrija) get medical help immediately. 
Takoj poiščite zdravniško pomoč, če ste uporabili večji odmerek zdravila Inbrija, kot bi smeli (ali pa je kdo drug nehote pogoltnil zdravilo Inbrija).
Tests 
Pregled
Do not load 2 capsules at the same time. 
V inhalator ne smete vstaviti 2 kapsul naenkrat.
It is recommended to administer this medicinal product cautiously to patients with severe hepatic impairment. 
Priporoča se previdnost pri dajanju tega zdravila bolnikom s hudo okvaro jeter.
Tear off package of 2 capsules. 
Odtrgajte ovojnino z 2 kapsulama.
Neoplasm benign, malignant and unspecified (incl. 
Benigne, maligne in neopredeljene novotvorbe
A dose adjustment of levodopa may be required with concomitant use of COMT inhibitors. 
Pri sočasni uporabi zaviralcev COMT je lahko potrebna prilagoditev odmerka levodope.
Symptomatic postural hypotension has occurred when combinations of levodopa and a dopadecarboxylase inhibitor are added to the treatment of patients already receiving certain antihypertensives. 
Pri dodajanju kombinacij levodope in zaviralca dopa-dekarboksilaze k zdravljenju bolnikov, ki so se že zdravili z določenimi antihipertenzivi, se je pojavila simptomatska ortostatska hipotenzija.
The pharmacokinetics of the major levodopa metabolites 3-O-methyldopa (3-OMD), 3,4dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were studied following administration of a single inhaled dose of Inbrija and a single oral carbidopa/levodopa 25 mg/100 mg immediate release tablet. 
3,4-dihidroksifenilocetne kisline (DOPAC) in homovanilinske kisline (HVA), so proučili po aplikaciji enkratnega inhaliranega odmerka zdravila Inbrija in enkratnega peroralnega odmerka karbidope/levodope 25 mg/100 mg tableta s takojšnjim sproščanjem.
Dose adjustment of the antihypertensive medicinal products may be required during concomitant use of Inbrija. 
Pri sočasni uporabi zdravila Inbrija je lahko potrebna prilagoditev odmerka antihipertenzivov.
The change from baseline for DLCO was compared between the Inbrija treatment group and the observational cohort; at the end of 12 months, there was no significant difference in the change from baseline between Inbrija group and the observational cohort in DLCO. 
Na koncu 12 mesecev ni bilo značilnih razlik v spremembi DLCO v primerjavi z izhodiščem med skupino z zdravilom Inbrija in opazovalno kohorto.
Intercurrent respiratory infection 
Sočasna okužba dihal
- A complete dose is 2 capsules taken one right after the other. 
- 2 kapsuli, ki predstavljata celoten odmerek, je treba vzeti takoj eno za drugo.
Cases of falsely diagnosed pheochromocytoma in patients on levodopa/dopa-decarboxylase inhibitor therapy have been reported very rarely. 
Zelo redko so poročali o primerih napačno diagnosticiranega feokromocitoma pri bolnikih, ki so se zdravili z levodopo/zaviralcem dopa-dekarboksilaze.
Parkinson's disease affects your movement and it is treated with a medicine that you take regularly. 
Parkinsonova bolezen vpliva na vaše gibanje.
The capsules must only be removed from the blister immediately before use. 
Kapsule se smejo vzeti iz pretisnega omota šele tik pred uporabo.
Dispose and store Step 12: Dispose of used capsules 
12. korak: Odstranite uporabljene kapsule.
A total of 114 patients were randomised and treated with Inbrija 66 mg (two 33 mg capsules) and 112 patients received placebo. 
33 mg kapsuli) in 112 bolnikov je prejelo placebo.
Dyspepsia, 
disfonija,
Subject features 
Lastnosti udeležencev
You can use a dry cotton swab or tissue to wipe the outside of the inhaler. 
Zunanjost inhalatorja lahko obrišete s suho vatno blazinico ali robčkom.
Inbrija 33 mg inhalation powder, hard capsules levodopa 
Inbrija 33 mg prašek za inhaliranje, trde kapsule levodopa
Baseline mean (SD) LS mean change Mean diff. (95% CI) p-value 
Povprečje ob izhodišču (SD) LS povprečne spremembe Povprečna sprememba (95-% IZ)
Colfosceril palmitate (DPPC) Sodium chloride 
Vsebina kapsule kolfoscerilpalmitat (DPPC)
Somnolence and episodes of sudden sleep onset 
Opis izbranih neželenih učinkov Nenaden nastop spanca
Agranulocytosis, Thrombocytopenia, Leukopenia 
Bolezni krvi in limfatičnega sistema anemija, agranulocitoza, trombocitopenija, levkopenija
Hepatic impairment 
Peptična razjeda
Patients may experience new or worsening mental status and behavioural changes, which may be severe, including psychotic-like and suicidal behaviour during levodopa treatment or after starting or increasing the dose of levodopa. 
Duševne motnje Med zdravljenjem z levodopo ali po uvedbi/povečanju odmerka levodope lahko pri bolnikih pride do spremembe ali poslabšanja duševnega stanja in vedenjskih sprememb, tudi resnih, vključno s psihotičnemu podobnim in samomorilnim vedenjem.
Dizziness, 
izpuščaj,
Each carton includes blisters of 4 capsules. 
V vsaki škatli so pretisni omoti, od katerih vsak vsebuje po 4 kapsule.
You may need to have tests on your heart, liver, kidney, and blood cell tests during long-term treatment with your medicines. 
Morda boste med dolgotrajnim zdravljenjem s svojimi zdravili morali opravljati preiskave srca, jeter,
A clinical study was performed with Inbrija 66 mg (2 x 33 mg capsules) administered to 56 healthy subjects (31 non-smokers and 25 smokers). 
Izvedli so klinično študijo, v kateri so 56 zdravim prostovoljcem (31 nekadilcem in 25 kadilcem) dali 66 mg (2 × 33 mg kapsula) zdravila Inbrija.
Acorda Therapeutics Ireland Limited 10 Earlsfort Terrace Dublin 2, D02 T380 
Dublin 2, D02 T380
Step 10: Remove capsule from inhaler Twist and pull off the mouthpiece 
10. korak: Odstranite kapsulo iz inhalatorja.
For use only with the inhaler provided in the pack. 
Za uporabo samo s priloženim inhalatorjem.
Read these instructions before you start using Inbrija. 
Preden začnete uporabljati zdravilo Inbrija, preberite ta navodila.
Inbrija 33 mg inhalation powder, hard capsules 
Inbrija 33 mg prašek za inhaliranje, trde kapsule
When experiencing an OFF period, subjects could use inhaled levodopa on demand up to five times a day. 
Pri pojavu obdobja izklopa so udeleženci smeli po potrebi uporabiti levodopo za inhaliranje do petkrat na dan. Apomorfin kot osnovno zdravilo ni bil dovoljen.
Step 7: Hold inhaler away and breathe out Stand or sit with your head and chest upright. 
7. korak: Držite inhalator stran od sebe in izdihnite.
How to store Inbrija 
Shranjevanje zdravila Inbrija
In a subpopulation of the 12-week study, serial spirometry measurements were performed at 15, 30 and 60 minutes following the first dose of Inbrija 66 mg or placebo. 
60 minut po prvem odmerku 66 mg zdravila Inbrija ali placeba.
• Only remove the capsules from the blister immediately before use. 
• Kapsuli vzemite iz pretisnega omota šele tik pred uporabo.
Adverse reactions reported with oral levodopa 
Neželeni učinki, o katerih so poročali pri peroralni levodopi
- Keep this leaflet. 
Pritrdite pokrovček.
Abdominal pain, Constipation, Diarrhoea, 
Očesne bolezni zamegljen vid, diplopija, midriaza,
Do not swallow capsules. 
Kapsul ne smete pogoltniti.
Responders ONb n = 97a n = 97a 
Odzivni bolniki z vklopomb n = 97a n = 97a
Sudden onset of sleep (see section 4.4), 
Neznana (glejte poglavje 4.4),
Weight increased 
povečana telesna masa
Contents of the pack and other information What Inbrija contains 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Inbrija - Učinkovina je levodopa.
Because of the risk of bronchospasm, use of levodopa inhalation powder in patients with asthma, chronic obstructive pulmonary disease (COPD), or other chronic underlying lung disease is not recommended. 
kronično obstruktivno pljučno boleznijo (KOPB) ali drugo kronično osnovno pljučno boleznijo ne priporoča.
Abnormal thinking including anxiety, depression, being agitated, being paranoid, delusional, or disorientated, aggressive behaviour and delirious; 
halucinacijami, zmedenostjo, psihotičnemu podobnemu vedenju, dezorientacijo, agresivnim vedenjem, agitacijo in delirijem.
A symptom complex that resembles neuroleptic malignant syndrome (characterised by elevated temperature, muscular rigidity, altered consciousness, and autonomic instability), with no other obvious aetiology, has been reported in association with rapid dose reduction, withdrawal of, or changes in the background dopaminergic therapy. 
V povezavi s hitrim zmanjšanjem odmerka, odtegnitvijo ali spremembami osnovnega dopaminergičnega zdravljenja so poročali o kompleksu simptomov, podobnem nevroleptičnemu malignemu sindromu (za katerega so značilne zvišana telesna temperatura, mišična rigidnost, spremenjena zavest in avtonomna nestabilnost).
Agitation, 
motnje hoje,
Allergic oedema 
Bolezni imunskega sistema alergijski edem
Black iron oxide (E 172) Propylene glycol Potassium hydroxide 
Črnilo šelak črni železov oksid (E 172)
See section 4.4 regarding withdrawal emergent hyperpyrexia and confusion. 
Za informacije o hiperpireksiji in zmedenosti, ki nastopita ob odtegnitvi, glejte poglavje 4.4.
- The capsules must only be removed from the blister pack immediately before use. 
- Kapsule smete vzeti iz pretisnega omota šele tik pred uporabo.
Package leaflet: Information for the patient Inbrija 33 mg inhalation powder, hard capsules levodopa 
Navodilo za uporabo Inbrija 33 mg prašek za inhaliranje, trde kapsule levodopa
risperidone, chlorpromazine, fluphenazine decanoate, phenotiazine, butyrophenone, or trifluoperazine; - metoclopramide to treat nausea; - isoniazid, an antibiotic to treat tuberculosis; - medicines for high blood pressure, as the dose may need to be adjusted; - medicines for depression called tricyclic antidepressants such as clomipramin, desipramin, or doxepin; - amantadine to treat flu or your Parkinson's disease. 
- zdravila za zdravljenje visokega krvnega tlaka, saj bo morda treba prilagoditi odmerek; - zdravila proti depresiji, ki jim pravimo triciklični antidepresivi, kot so klomipramin, desipramin ali doksepin;
Smoking 
kolcanje
Respiration abnormal, Dysphonia, Hiccups 
Bolezni kože in podkožja angioedem, hiperhidroza,
Cognitive disorder, Horner's syndrome, Dementia 
Hornerjev sindrom,
- melanoma (a type of skin cancer) or suspicious skin growths or marks. 
- novi ali povečani nenormalni telesni gibi (diskinezija); - občutek omotičnosti ob vstajanju (nizek krvni tlak); - melanom (vrsta kožnega raka) ali sumljive spremembe ali izrastki na koži.
Restless legs syndrome, Neuroleptic malignant syndrome (see section 4.4), Ataxia, 
nevroleptični maligni sindrom (glejte poglavje 4.4),
Orthostatic hypotension (see section 4.4), 
Žilne bolezni ortostatska hipotenzija (glejte poglavje 4.4), hipertenzija, sinkopa,
Caution should be exercised when interpreting the plasma and urine levels of catecholamines and their metabolites in patients on levodopa or levodopa/dopadecarboxylase inhibitor therapy. 
Pri bolnikih, zdravljenih z levodopo/zaviralcem dopa-dekarboksilaze je potrebna previdnost pri interpretaciji koncentracij kateholaminov in njihovih presnovkov v plazmi in urinu.
Carefully peel back the foil and take out 1 capsule. 
Previdno povlecite in odstranite folijo ter vzemite
Due to cough, 2% of subjects withdrew from the clinical studies with Inbrija. 
Inbrija izstopilo 2 % udeležencev.
• Dispose of the inhaler after you are finished all of the capsules in the carton. 
• Ko porabite vse kapsule iz škatle, zavrzite inhalator.
Bronchospasm in patients with lung disease 
4.4 Posebna opozorila in previdnostni ukrepi Bronhospazem pri bolnikih s pljučno boleznijo
Step 13: Store inhaler Make sure there are no capsules in the inhaler 
13. korak: Shranite inhalator.
Delusion 
demenca